Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
Open accessThe DOI matches its Crossref record; 240 of the 241 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
BACKGROUND: Pharmaceuticals with targets in the cholinergic transmission have been used for decades and are still fundamental treatments in many diseases and conditions today. Both the transmission and the effects of the somatomotoric and the parasympathetic nervous systems may be targeted by such treatments. Irrespective of the knowledge that the effects of neuronal signalling in the nervous systems may include a number of different receptor subtypes of both the nicotinic and the muscarinic receptors, this complexity is generally overlooked when assessing the mechanisms of action of pharmaceuticals. METHODS: We have search of bibliographic databases for peer-reviewed research literature focused on the cholinergic system. Also, we have taken advantage of our expertise in this field to deduce the conclusions of this study. RESULTS: Presently, the life cycle of acetylcholine, muscarinic receptors and their effects are reviewed in the major organ systems of the body. Neuronal and non-neuronal sources of acetylcholine are elucidated. Examples of pharmaceuticals, in particular cholinesterase inhibitors, affecting these systems are discussed. The review focuses on salivary glands, the respiratory tract and the lower urinary tract, since the complexity of the interplay of different muscarinic receptor subtypes is of significance for physiological, pharmacological and toxicological effects in these organs. CONCLUSION: Most pharmaceuticals targeting muscarinic receptors are employed at such large doses that no selectivity can be expected. However, some differences in the adverse effect profile of muscarinic antagonists may still be explained by the variation of expression of muscarinic receptor subtypes in different organs. However, a complex pattern of interactions between muscarinic receptor subtypes occurs and needs to be considered when searching for selective pharmaceuticals. In the development of new entities for the treatment of for instance pesticide intoxication, the muscarinic receptor selectivity needs to be considered. Reactivators generally have a muscarinic M2 receptor acting profile. Such a blockade may engrave the situation since it may enlarge the effect of the muscarinic M3 receptor effect. This may explain why respiratory arrest is the major cause for deaths by esterase blocking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“we stimulated RAW 264.7wt and RAW 264.7α7ko cells for 4 h with varying concentrations of ACh (in the presence of pyridostigmine49) and observed significant induction of IL-6 production in RAW 264.7wt cells but not in RAW 264.7α7ko cells (Figure 5F).”
From B cell-derived acetylcholine promotes liver regeneration by regulating Kupffer cell and hepatic CD8+ T cell function (2025) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · cited 1×
“At the motor neurons, presynaptic nicotinic receptors facilitate mobilization of a reserve pool of acetylcholine, thereby enhancing the cholinergic transmission [37].”
Muscarinic Receptors—Characterization, coupling and function
Caulfield, M. P. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90027-b · Cited by 1,277
Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., & Vincent, A. (2001) · Nature Medicine · doi:10.1038/85520 · Cited by 1,183 · cited 1×
“It has been shown that many seronegative patients have antibodies that bind to the muscle-specific tyrosine kinase that anchors and clusters the nicotinic receptor at the postsynaptic membrane [139].”
Inestrosa, N. C., Alvarez, A., Pérez, C. A., Moreno, R. D., Vicente, M., Linker, C., Casanueva, O. I., Soto, C., & Garrido, J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80108-7 · Cited by 1,101
Suicide mortality in India: a nationally representative survey
Patel, V., Ramasundarahettige, C., Vijayakumar, L., Thakur, J., Gajalakshmi, V., Gururaj, G., Suraweera, W., & Jha, P. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60606-0 · Cited by 936
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Perry, E., Walker, M., Grace, J., & Perry, R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01361-7 · Cited by 763 · cited 1×
“In contrast to the periphery, acetylcholine primarily acts as a neuromodulator within the central nervous system [32].”
Kryger, G., Silman, I., & Sussman, J. L. (1999) · Structure · doi:10.1016/s0969-2126(99)80040-9 · Cited by 757 · cited 1×
“Its efficacy is ensured by its simultaneous binding to the active site and to the peripheral anionic site of the enzyme [132], which has been reported to enhance Aβ aggregation [133].”
Research works printed but not linked: 2
- [93]Marrs T.C. Organophosphate poisoning. Pharmacol. Ther. 1993 58 1 51 66 [http://dx.doi.org/10.1016/0163-7258(93)90066-M]. [PMID: 8415873]. 8415873 · DOI · Paper page
- [143]Garcia-Carrasco M. Escarcega R.O. Fuentes-Alexandro S. Riebeling C. Cervera R. Therapeutic options in autoimmune myasthenia gravis. Autoimmun. Rev. 2007 6 6 373 378 [http:// dx.doi.org/10.1016/j.autrev.2007.01.001]. [PMID: 17537383]. 17537383 · DOI
Cited by
Natural cholinesterase inhibitors from marine organisms
Moodie, L. W. K., Sepčić, K., Turk, T., Frangež, R., & Svenson, J. (2019) · Natural Product Reports · doi:10.1039/c9np00010k · Cited by 109
Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases
Felder, C. C., Goldsmith, P. J., Jackson, K. A., Sanger, H., Evans, D. A. P., Mogg, A. J., & Broad, L. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.028 · Cited by 98
Anticholinergic medication: Related dry mouth and effects on the salivary glands
Arany, S., Kopycka‐Kędzierawski, D. T., Caprio, T. V., & Watson, G. E. (2021) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2021.08.015 · Cited by 90
Morozova, V., Cohen, L. S., Makki, A. E.-H., Shur, A., Pilar, G., El Idrissi, A., & Alonso, A. D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00403 · Cited by 63
Pronin, A. N., Wang, Q., & Slepak, V. Z. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.109678 · Cited by 58
“Receptors of acetylcholine and proteins involved in its synthesis, secretion and degradation are established targets for pharmacological intervention (reviews (Kruse et al., 2014b; Soukup et al., 2017; Wess, 2004)).”
Metadata
- Authors
- Soukup, O., Winder, M., Killi, U. K., Wsol, V., Jun, D., Kuca, K., & Tobin, G.
- Affiliations
- University of Gothenburg (SE)
- Charles University (CZ)
- University Hospital Hradec Králové (CZ)
- Corresponding author
- Tobin, Gunnar
- Venue
- Current Neuropharmacology
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2017-04-11
- Volume
- 15
- Issue
- 4
- Pages
- 637-653
- ISSN
- 1570-159X (ISSN-L)
- PMC
- PMC5543679
- OpenAlex
- W2413641555
- Cited by
- 34
- References
- 239
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 1 · 2017: 1
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Current Neuropharmacology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Fakultní nemocnice Hradec Králové (00179906)
- European Regional Development Fund (ED2.1.00/03.0078)
- National Institute of Mental Health (ED2.1.00/03., ED2.1.00/03.0078)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- acetylcholinesterase inhibitors, muscarinic receptors, muscarinic receptor subtypes, cholinergic neurotransmission, antimuscarinic agents, acetylcholine, salivary glands, respiratory tract, lower urinary tract, M2 muscarinic receptor, M3 muscarinic receptor, pesticide poisoning, adverse drug reactions, receptor selectivity
- MeSH terms
- Animals, Cholinesterase Inhibitors, Humans, Receptors, Muscarinic, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment. https://app.cochat.ai/papers/10.2174/1570159x14666160607212615
- The paper
- Soukup, O., Winder, M., Killi, U. K., Wsol, V., Jun, D., Kuca, K., & Tobin, G. (2017). Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment. Current Neuropharmacology. https://doi.org/10.2174/1570159x14666160607212615
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.